Niraparib
Showing 176 - 186 of 186
Metastatic Melanoma Trial in San Francisco (Olaparib, Pembrolizumab)
Recruiting
- Metastatic Melanoma
-
San Francisco, CaliforniaCalifornia Pacific Medical Center Research Institute
Apr 30, 2021
Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer Trial in Italy (Carboplatin, Paclitaxel,
Recruiting
- Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Carboplatin
- +3 more
-
Legnago, Italy
- +6 more
Aug 24, 2021
Ovarian Cancer, Epithelial Ovarian Cancer, Ovarian Cancer, Epithelial Trial in Wuhan (CRS+HIPEC, CRS alone)
Recruiting
- Ovarian Cancer
- +4 more
- CRS+HIPEC
- CRS alone
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Sep 4, 2020
Recurrent Ovarian Cancer Trial (Niraparib)
Approved for marketing
- Recurrent Ovarian Cancer
- Niraparib
- (no location specified)
Apr 13, 2017
Advanced Malignant Pleural or Peritoneal Mesothelioma Trial (Talazoparib)
Not yet recruiting
- Advanced Malignant Pleural or Peritoneal Mesothelioma
- (no location specified)
Jul 8, 2020
Ovarian Cancer Trial (MK-4827 + pegylated liposomal doxorubicin)
Terminated
- Ovarian Cancer
- MK-4827 + pegylated liposomal doxorubicin
- (no location specified)
Oct 18, 2016
